{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:47:48Z","timestamp":1788223668131,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Currents in Pharmacy Teaching and Learning"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cptl.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T09:19:08Z","timestamp":1668590348000},"page":"1471-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Contact based intervention reduces stigma among pharmacy students"],"prefix":"10.1016","volume":"14","author":[{"given":"Christine R.","family":"Bakos-Block","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Al Rawwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylou","family":"Cardenas-Turanzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Champagne-Langabeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"50\u201351","key":"10.1016\/j.cptl.2022.10.002_bb0005","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.cptl.2022.10.002_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08897077.2017.1356791","article-title":"Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically","volume":"38","author":"Schepis","year":"2017","journal-title":"Subst Abus"},{"key":"10.1016\/j.cptl.2022.10.002_bb0015","series-title":"Key substance use and mental health indicators in the United States: results from the 2020 National Survey on drug use and health (HHS publication no. PEP21\u201307\u201301-003, NSDUH Series H-56)","year":"2021"},{"key":"10.1016\/j.cptl.2022.10.002_bb0020","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2022"},{"key":"10.1016\/j.cptl.2022.10.002_bb0025","series-title":"Drug Overdose Deaths in the Untied States, 1999\u20132020","author":"Hedegaard","year":"2021"},{"issue":"10","key":"10.1016\/j.cptl.2022.10.002_bb0030","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.mayocp.2019.03.029","article-title":"Medication-assisted treatment for opioid use disorder","volume":"94","author":"Oesterle","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0035","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cptl.2022.10.002_bb0040","series-title":"Comprehensive addiction and recovery act of 2016 (CARA). Pub L No. 114-198","year":"2016"},{"key":"10.1016\/j.cptl.2022.10.002_bb0045","author":"Use of Telemedicine While Providing Medication Assisted Treatment (MAT)"},{"key":"10.1016\/j.cptl.2022.10.002_bb0050","unstructured":"Multiple cause of death 1999-2020. CDC WONDER Online Database. Centers for Disease Control and Prevention. Accessed 21 October 2022. https:\/\/wonder.cdc.gov\/controller\/datarequest\/D77."},{"issue":"6","key":"10.1016\/j.cptl.2022.10.002_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ADM.0000000000000523","article-title":"Disparities between US opioid overdose deaths and treatment capacity: a geospatial and descriptive analysis","volume":"13","author":"Langabeer","year":"2019","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.cptl.2022.10.002_bb0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1176\/appi.ps.201600056","article-title":"Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies","volume":"68","author":"Kennedy-Hendricks","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review","volume":"107","author":"Livingston","year":"2012","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.cptl.2022.10.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.cptl.2022.10.002_bb0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4103\/IJPSYM.IJPSYM_171_18","article-title":"Quality of life and its relationship with perceived stigma among opioid use disorder patients: an exploratory study","volume":"40","author":"Singh","year":"2018","journal-title":"Indian J Psychol Med"},{"issue":"5","key":"10.1016\/j.cptl.2022.10.002_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1465-3362.2010.00173.x","article-title":"Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach","volume":"29","author":"Brener","year":"2010","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0033291714000129","article-title":"What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies","volume":"45","author":"Clement","year":"2015","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ADM.0000000000000355","article-title":"Correlates of stigma severity among persons seeking opioid detoxification","volume":"12","author":"Bozinoff","year":"2018","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11469-016-9719-6","article-title":"Stigma and social support in pharmaceutical opioid treatment populations: a scoping review","volume":"15","author":"Cooper","year":"2017","journal-title":"Int J Ment Health Addict"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/dar.12601","article-title":"Perceived stigma and social support in treatment for pharmaceutical opioid dependence","volume":"37","author":"Cooper","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.cptl.2022.10.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.cptl.2022.10.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108217","article-title":"Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians","volume":"216","author":"Kennedy-Hendricks","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"10.1016\/j.cptl.2022.10.002_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: a systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.cptl.2022.10.002_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/apc.2018.0114","article-title":"HIV-related stigma by healthcare providers in the United States: a systematic review","volume":"32","author":"Geter","year":"2018","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.cptl.2022.10.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12266","article-title":"Impact of weight bias and stigma on quality of care and outcomes for patients with obesity","volume":"16","author":"Phelan","year":"2015","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"10.1016\/j.cptl.2022.10.002_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08897077.2020.1787300","article-title":"Medication treatment for opioid use disorder and community pharmacy: expanding care during a national epidemic and global pandemic","volume":"41","author":"Cochran","year":"2020","journal-title":"Subst Abuse"},{"issue":"5","key":"10.1016\/j.cptl.2022.10.002_bb0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0897190016656673","article-title":"Prescription opioid misuse among rural community pharmacy patients: pilot study for screening and implications for future practice and research","volume":"30","author":"Cochran","year":"2017","journal-title":"J Pharm Pract"},{"issue":"7","key":"10.1016\/j.cptl.2022.10.002_bb0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajhp\/zxab003","article-title":"Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic","volume":"78","author":"Peckham","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"10.1016\/j.cptl.2022.10.002_bb0150","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/add.15353","article-title":"Buprenorphine physician\u2013pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network","volume":"116","author":"Wu","year":"2021","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.cptl.2022.10.002_bb0155","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.sapharm.2018.07.011","article-title":"Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk","volume":"15","author":"Strand","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.cptl.2022.10.002_bb0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cptl.2022.01.008","article-title":"Expanding naloxone education in the doctor of pharmacy curriculum","volume":"14","author":"Musco","year":"2022","journal-title":"Curr Pharm Teach Learn"},{"issue":"4","key":"10.1016\/j.cptl.2022.10.002_bb0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/08897077.2019.1616349","article-title":"Pharmacists\u2019 attitudes toward dispensing naloxone and medications for opioid use disorder: a scoping review of the literature","volume":"40","author":"Muzyk","year":"2019","journal-title":"Subst Abuse"},{"key":"10.1016\/j.cptl.2022.10.002_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2018.04.020","article-title":"State naloxone access laws are associated with an increase in the number of nalxone prescriptions dispensed in retail pharmacies","volume":"189","author":"Xu","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.cptl.2022.10.002_bb0175","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.amepre.2021.05.042","article-title":"Trends in state-level pharmacy-based naloxone dispensing rates, 2012-2019","volume":"61","author":"Guy","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cptl.2022.10.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky","volume":"85","author":"Cooper","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0185","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states","volume":"57","author":"Green","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.cptl.2022.10.002_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108729","article-title":"Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden","volume":"224","author":"Kazerouni","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.cptl.2022.10.002_bb0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s40596-014-0067-1","article-title":"Reducing stigma towards substance users through an educational intervention: harder than it looks","volume":"38","author":"Crapanzano","year":"2014","journal-title":"Acad Psychiatry"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-016-0050-9","article-title":"Community pharmacists\u2019 experiences in mental illness and addictions care: a qualitative study","volume":"11","author":"Murphy","year":"2016","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0205","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s40596-017-0771-8","article-title":"A focused addiction curriculum and its impact on student knowledge, attitudes, and confidence in the treatment of patients with substance use","volume":"42","author":"Feeley","year":"2018","journal-title":"Acad Psychiatry"},{"issue":"6","key":"10.1016\/j.cptl.2022.10.002_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/NNE.0000000000000647","article-title":"Teaching nursing students how to decrease the stigma against people who use drugs","volume":"44","author":"Dion","year":"2019","journal-title":"Nurse Educ"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40596-017-0702-8","article-title":"Change in medical student attitudes toward patients with substance use disorders after course exposure","volume":"42","author":"Koyi","year":"2018","journal-title":"Acad Psychiatry"},{"issue":"4","key":"10.1016\/j.cptl.2022.10.002_bb0220","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.5688\/ajpe7631","article-title":"A music assignment to develop pharmacy students\u2019 empathy toward people with opioid use disorder","volume":"84","author":"Silvia","year":"2020","journal-title":"Am J Pharm Educ"},{"issue":"9","key":"10.1016\/j.cptl.2022.10.002_bb0225","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.5688\/ajpe7199","article-title":"A classroom activity to increase student pharmacists confidence in dealing with the opioid epidemic","volume":"83","author":"Murnane","year":"2019","journal-title":"Am J Pharm Educ"},{"key":"10.1016\/j.cptl.2022.10.002_bb0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2019.01.005","article-title":"A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: evidence for construct validity","volume":"99","author":"Yang","year":"2019","journal-title":"J Subst Abus Treat"},{"issue":"8","key":"10.1016\/j.cptl.2022.10.002_bb0235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/ACM.0000000000004674","article-title":"The status of SBIRT training in health professions education: a cross-discipline review and evaluation of SBIRT cirricula and educational research","volume":"97","author":"McAfee","year":"2022","journal-title":"Acad Med"},{"issue":"suppl 2","key":"10.1016\/j.cptl.2022.10.002_bb0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/add.13675","article-title":"Screening, brief intervention and referral to treatment: implications of SAMHSA\u2019s SBIRT initiative for substance abuse policy and practice","volume":"112","author":"Babor","year":"2017","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cptl.2022.10.002_bb0250","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cptl.2019.02.013","article-title":"Preparing student pharmacists to identify opioid misuse, prevent overdose and prescribe naloxone","volume":"11","author":"Skoy","year":"2019","journal-title":"Curr Pharm Teach Learn"},{"issue":"10","key":"10.1016\/j.cptl.2022.10.002_bb0255","doi-asserted-by":"crossref","first-page":"ajpe8001","DOI":"10.5688\/ajpe8001","article-title":"Opioid-related education provided by continuing education divisions at US pharmacy schools","volume":"84","author":"Renfro","year":"2020","journal-title":"Am J Pharm Educ"},{"issue":"3","key":"10.1016\/j.cptl.2022.10.002_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/pharmacy8030144","article-title":"Stigma of opioid use disorder and its indirect effects on student pharmacists\u2019 perceptions and attitudes","volume":"8","author":"Hall","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08897077.2021.1944955","article-title":"The effects of screening brief intervention referral to treatment (SBIRT) training on health professional trainees\u2019 regard, attitudes, and beliefs toward patients who use substances","volume":"43","author":"Lukowitsky","year":"2022","journal-title":"Subst Abus"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ajad.12406","article-title":"Changes in psychiatry residents\u2019 attitudes towards individuals with substance use disorders over the course of residency training","volume":"26","author":"Avery","year":"2017","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.cptl.2022.10.002_bb0275","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/00224545.2014.953028","article-title":"Gendered mental disorders: masculine and feminine stereotypes about mental disorders and their relation to stigma","volume":"154","author":"Boysen","year":"2014","journal-title":"J Soc Psychol"},{"issue":"3","key":"10.1016\/j.cptl.2022.10.002_bb0280","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10597-021-00849-y","article-title":"Influence of provider gender on mental health stigma","volume":"58","author":"Kaitz","year":"2022","journal-title":"Community Ment Health J"},{"issue":"12","key":"10.1016\/j.cptl.2022.10.002_bb0285","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/aje\/kwq304","article-title":"Stigma and treatment for alcohol disorders in the United States","volume":"172","author":"Keyes","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.cptl.2022.10.002_bb0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2010.12.005","article-title":"Standardized measures for substance use stigma","volume":"116","author":"Brown","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.cptl.2022.10.002_bb0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/ADM.0000000000000552","article-title":"Sociodemographic characteristics and the stigmatization of prescription opioid addiction","volume":"14","author":"Goodyear","year":"2020","journal-title":"J Addict Med"}],"container-title":["Currents in Pharmacy Teaching and Learning"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877129722002957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877129722002957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:28:47Z","timestamp":1761798527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877129722002957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1877129722002957"],"URL":"https:\/\/doi.org\/10.1016\/j.cptl.2022.10.002","relation":{},"ISSN":["1877-1297"],"issn-type":[{"value":"1877-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contact based intervention reduces stigma among pharmacy students","name":"articletitle","label":"Article Title"},{"value":"Currents in Pharmacy Teaching and Learning","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cptl.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}